Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
- Journal
- ChemMedChem
In The Last Decade
doi.org/10.1002/cmdc.200600221 →Countries where authors are citing Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
This map shows the geographic impact of Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase more than expected).
Fields of papers citing Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
This network shows the impact of Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase.
About Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
This paper, published in 2006, received 517 indexed citations . Written by Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li, Brian E. Schultz, Paul A. Sprengeler, Leland C. Burrill, Rohan Mendonca, M. D. Sweeney, Paul G. Grothaus and Douglas A. Jeffery covering the research area of Oncology, Genetics and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Genetics (308 citations), Molecular Biology (243 citations) and Pathology and Forensic Medicine (187 citations). Published in ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1002/cmdc.200600221.